Genetic Diseases of Mucopolysaccharide Catabolism; Single-Enzyme Deficiency Disorders
Elizabeth F. Neufeld
openalex +2 more sources
Genetic Eye Disease: Retinitis Pigmentosa and Other Inherited Eye Diseases [PDF]
B. Jay
openalex +1 more source
TRPM8 levels determine tumor vulnerability to channel agonists
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo+18 more
wiley +1 more source
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases. [PDF]
Kim-McManus O+14 more
europepmc +1 more source
URIDINE MONOPHOSPHATE KINASE (UMPK)-A NEW GENETIC MARKER FOR SUSCEPTIBILITY TO HAEMOPHILUS INFLUENZAE TYPE B (HIB) DISEASE [PDF]
Gloria M. Petersen+5 more
openalex +1 more source
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine+10 more
wiley +1 more source
Case series of kidney transplantation in two pediatric recipients with rare genetic diseases and intellectual disability. [PDF]
Mata M+5 more
europepmc +1 more source
Vaccines '88: New Chemicals and Genetic Approaches to Vaccination. Prevention of AIDS and other viral, bacterial and parasitic diseases. Edited by H. Ginsberg, F. Brown, R. A. Lerner and R. M. Channock. New York: Cold Spring Harbor Labortory. 1988. 396 pages. Paper $9500. ISBN 0 87969 210 X. [PDF]
Robert G. Ridley
openalex +1 more source
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte+10 more
wiley +1 more source